ctDNA markers
Showing 1 - 25 of 9,466
Postoperative Recurrence Monitoring of Breast Cancer
Recruiting
- Breast Cancer
-
Beijing, Beijing, ChinaBeijing Friendship Hospital Affiliated to Capital Medical Univer
May 4, 2023
Breast Cancer, Breast Tumors, Cancer, Breast Trial in Toronto (Genomic Markers (CTC/ctDNA))
Recruiting
- Breast Cancer
- +2 more
- Genomic Markers (CTC/ctDNA)
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Oct 13, 2021
Using Peripheral Blood Circulating Tumor DNA in Cervical Cancer
Recruiting
- Locally Advanced Cervical Cancer
- detect HPV and genetic variants
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 28, 2022
Lung Cancer Trial in Netherlands
Not yet recruiting
- Lung Cancer
-
Heerlen, Limburg, Netherlands
- +4 more
Oct 23, 2023
Early Diagnosis of Digestive System Cancers
Recruiting
- Esophageal Cancer
- +3 more
-
Shanghai, Shanghai, China
- +3 more
Jun 19, 2022
ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.
Recruiting
- Breast Cancer Female
- +4 more
-
Ho Chi Minh City, Vietnam
- +1 more
Oct 16, 2023
Colorectal Cancer, Colon Cancer, Rectum Cancer Trial in Houston (Regorafenib, XmAb20717)
Not yet recruiting
- Colorectal Cancer
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 31, 2023
Postoperative Recurrence Monitoring of Colorectal Cancer
Recruiting
- Colorectal Cancer
-
Beijing, Beijing, ChinaCancer hospital Chinese academy of medical sciences
Jul 1, 2022
Renal Cancer Trial in Aarhus N
Enrolling by invitation
- Renal Cancer
-
Aarhus N, DenmarkUrology Department Aarhus University Hospital
Nov 21, 2023
The Diverticulitis Study
Recruiting
- Colonic Diverticulitis
- +2 more
-
Herlev, Capital Region Of Denmark, Denmark
- +4 more
Sep 1, 2023
Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
Recruiting
- Esophageal Squamous Cell Carcinoma
-
Shijiazhuang, Hebei, ChinaDepartment of Thoracic Surgery, Fourth Hospital of Hebei Medical
Oct 25, 2023
Disease Burden, Genetic Heterogeneity and Tumour Evolution in
Recruiting
- Thyroid Cancer
- Sample collection only
-
London, United KingdomThe Royal Marsden NHS Foundation Trust
Apr 28, 2023
MRD Application in Colorectal Cancer Patients
Recruiting
- Colorectal Cancer
- +2 more
-
Jinan, Shandong, ChinaJinan central hospital affiliated to Shandong First Medical Univ
Sep 1, 2023
Colorectal Cancer Trial in Guangzhou (Detection of ctDNA methylation)
Recruiting
- Colorectal Cancer
- Detection of ctDNA methylation
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Sep 25, 2022
Circulating Tumor DNA and T Cell Repertoire Predict
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Brain Metastases
- Whole-brain radiotherapy
-
Wuhan, Hubei, ChinaUnion hospital
Feb 12, 2023
Benchmarking of Top Performing ctDNA Diagnostics - Colorectal
Recruiting
- Colorectal Cancer Stage III
- Liver Metastasis Colon Cancer
-
Graz, Steiermark, Austria
- +14 more
Nov 1, 2023
ctDNA Methylation for Epithelial Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- +7 more
- CDO1 and HOXA9 methylation assay
-
Beijing, Beijing, ChinaLei Li
Mar 24, 2023
Gastrooesophageal Cancer Trial in United Kingdom (Trastuzumab deruxtecan)
Not yet recruiting
- Gastrooesophageal Cancer
- Trastuzumab deruxtecan
-
Southampton, Hampshire, United Kingdom
- +16 more
Jul 27, 2023
Carcinoma, Renal Cell Carcinoma, RCC Trial in Nanjing
Recruiting
- Carcinoma
- +4 more
-
Nanjing, Jiangsu, ChinaJinling Hospital, Affiliated Hospital of Medical School, Nanjing
Jun 30, 2023
Breast Cancer Trial in Ulm (Determination of tumormarkers (CA27.29, CEA, CA125), Determination of CTC levels, Determination of
Recruiting
- Breast Cancer
- Determination of tumormarkers (CA27.29, CEA, CA125)
- +3 more
-
Ulm, GermanyUniversity Hospital Ulm Gynecology/Obstetrics
Jan 12, 2023
Lung Trial in Charlotte (Biomarkers and ctDNA)
Recruiting
- Lung Cancer, Nonsmall Cell
- Blood and tissue samples
-
Charlotte, North CarolinaLevine Cancer Institute
Jan 17, 2023
To EstablishMolecular Typing System for Early Diagnosis of Lung
Recruiting
- Lung Cancer
-
Beijing, Beijing, ChinaChina-Japan Friendship Hospital
Jun 20, 2022
Triple Negative Breast Cancer (TNBC) Trial in United States (Combination of liposomal doxorubicin)
Not yet recruiting
- Triple Negative Breast Cancer (TNBC)
- Combination of liposomal doxorubicin
-
Elizabeth, New Jersey
- +7 more
Jul 13, 2023
Recurrent and Metastatic CRC After Surgery by Multi-omics
Not yet recruiting
- Colorectal Cancer Metastatic
- no intervention
- (no location specified)
Aug 11, 2022